Northwest Biotherapeutics Inc
NWBO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001072379
No open-market purchases or sales by Northwest Biotherapeutics Inc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $413.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $413.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NWBO, Q2 2026
No superinvestor reported holding NWBO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Northwest Biotherapeutics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 (view filing)7:49 PM ET | Jul 26 | 4 days | Malik NavidDirector | SSale | −657.9K | $0.38 | −$250.0K | –23.3M after | Derivative |
| Dec 1, 2023 (view filing) | Nov 16-17 | 15 daysLate | Malik NavidDirector | SSale | +570.0K | $0.8244 | +$469.9K | New position0 after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Northwest Biotherapeutics Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Compass Financial Management LLC | 1,215,500 | $227.1K | 0.03% | +1,215,500 | New |
| Wall Street Access Asset Management, LLC | 800,000 | $149.4K | 0.02% | +600,000+300.0% | Added |
| VSM Wealth Advisory, LLC | 80,574 | $15.1K | 0.00% | 00.0% | Unchanged |
| Opus Capital Group, LLC | 60,150 | $11.0K | 0.00% | 00.0% | Unchanged |
| Ethos Financial Group, LLC | 39,070 | $6.33K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 25,000 | $4.67K | 0.00% | 00.0% | Unchanged |
| Hantz Financial Services, Inc. | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% | 00.0% | Unchanged |